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Wepreviously have shown that cue-induced alcohol craving and propensity for higher drink-
ing are modulated by allelic differences in SLC6A4 associated with serotonin transporter
(5-HTT) expression level alterations. In an independent study, we characterized another
polymorphism, SNP rs1042173, in 3′-untranslated region (3′-UTR) of the same gene, which
also altered 5-HTT expression levels; the T allele of rs1042173 was associated with lower
mRNA and protein levels. In subsequent analyses, the TT genotype was found to be
associated with higher drinking intensity in alcohol-dependent (AD) individuals of Cau-
casian descent. Building upon these ﬁndings, we hypothesized that the low-expressing
TT genotype associated with intense drinking would predict higher craving for alcohol in
AD individuals. In this pilot study, we sought to test our hypothesis by examining 34 His-
panic AD volunteers (mean age, 34.8 years) for rs1042173 genotype-based [i.e., TT versus
TG/GG (Gx)] differences in subjective response to alcohol. We employed a human labo-
ratory paradigm and analyzed the data using a linear mixed-effects model (SAS® PROC
MIXED) to assess treatment, cue procedures, and genotype main effects as well as the
two-way interaction effects between them. On subjective “urge to drink” and “crave for a
drink,” we found a signiﬁcant main effect of the cue experiment (p ≤ 0.01) and an interac-
tion effect between genotype and cue effects (p< 0.05).TT genotype was associated with
higher urge to drink (p = 0.002) and crave for a drink (p = 0.005) when exposed to alcohol
cue. Our results not only support the hypothesis that rs1042173 is a genetic marker for
cue-induced alcohol craving among AD males but also are suggestive of a neurobiological
mechanism associated with the rs1042173-TT genotype that triggers a disproportionate
craving in response to alcohol consumption, which in turn may lead to more intense drink-
ing. Future studies with larger sample sizes are needed to characterize the interactive
effects of the serotonin transporter-linked polymorphic region (5′-HTTLPR)-L-allele reported
in our previous study and of the rs1042173-TT genotype on cue-induced alcohol craving.
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INTRODUCTION
Serotonin pathways are important modulators of the reward sys-
tem in the brain both in natural pleasurable activities such as
feeding and sexual activity and in addictive behavior. Serotonin-
containing neurons project diffusely to various areas known to be
involved in the reward system, including the nucleus accumbens,
ventral tegmental area, substantia nigra, hippocampus, amygdala,
and prefrontal cortex (Hayes and Greenshaw, 2011). The precise
mechanisms by which serotonin modulates the reward system are
still being elucidated. Nearly all of the serotonin receptor subtypes
have been linked to areas in the brain associated with addiction
and reward.
The presynaptic serotonin transporter (5-HTT) has been inves-
tigated extensively over the years in the addiction genetics ﬁeld
as an important regulator of drinking behavior (Heinz et al.,
2000). A wealth of literature exists on genetic associations between
5-HTT genetic polymorphisms and phenotypes of alcoholism;
among these, the most widely studied polymorphism is the 5-
HTT 5′-regulatory promoter region variant, the 5-HTT-linked
polymorphic region [5′-HTTLPR; long (L) and short (S) alleles].
Recently, Seneviratne et al. (2009) reported another allelic vari-
ation at the 5-HTT gene (SLC6A4) 3′-untranslated region (3′-
UTR) single-nucleotide polymorphism (T/G), rs1042173, altering
5-HTT mRNA and protein levels; the T allele-transfected HeLa
cells had signiﬁcantly lower mRNA and protein levels than the
G-allele-transfected cells. In the same study, in a group of alcohol-
dependent (AD), treatment-seeking individuals who were partic-
ipating in an outpatient clinical trial, the authors showed that TT
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genotype, compared with the TG/GG genotypes, was associated
with signiﬁcantly higher drinking intensity in Caucasian individ-
uals (Seneviratne et al., 2009). The authors also detected a similar,
albeit a non-signiﬁcant, trend in Hispanic individuals and spec-
ulated that the higher drinking intensity associated with the TT
genotype may have been due to lower levels of 5-HTT expres-
sion resulting in higher synaptic serotonin concentrations, which
in turn may lead to hazardous drinking behaviors (Seneviratne
et al., 2009). In a subsequent pharmacogenetic study, also con-
ducted by our group, we have shown that individuals of both
Caucasian and Hispanic descent carrying LL and TT genotypes
showed a reduction in their drinking severity compared with the
non-carriers when treated with an anti-serotonergic drug (John-
son et al., 2011). Taken together, these previous ﬁndings suggest
a modulatory effect of rs1042173 on the subjective response to
alcohol in individuals of both Caucasian and Hispanic descent.
In the present study, we utilized a human laboratory paradigm
to test whetherHispanic individuals whowere homozygous for the
T allele, compared with G-allele carriers, would display stronger
cue-induced craving for alcohol. Human laboratory paradigms
offer a unique advantage over an outpatient setting in that they
effectively minimize the inﬂuence of various other environmen-
tal factors on a behavioral phenotype, such as subjective response
to alcohol and propensity to drink, thereby reﬁning the genetic
effects on the phenotype (Kaplan et al., 1985; Walitzer and Sher,
1990; Ait-Daoud et al., 2009).
Additionally, we conducted an acute tryptophan depletion test,
which currently represents the most established human challenge
test to manipulate the central serotonergic system in vivo and
assess the behavioral effects of reduced serotonin metabolism in
the brain. The tryptophan depletion test also allows us to examine
whether acute tryptophan depletion (Delgado et al., 1991; Young
and Leyton, 2002; Neumeister, 2003) would alter the cue-induced
propensity to drink among AD individuals with the TT, TG, and
GG genotypes.
MATERIALS AND METHODS
SUBJECTS
A total of 34 Hispanic male AD individuals (aged between 21 and
50 years) were enrolled into the study. All subjects were in good
health as determined by a complete physical examination, electro-
cardiogram, and laboratory screening tests within an acceptable
range. Female participants had to have a negative pregnancy test
at intake and be willing to use an acceptable form of contra-
ception, which included an oral contraceptive pill, barriers and
spermicide, or hormonal implants. To be eligible, subjects had to
be actively drinking ≥21 standard drinks per week for males and
≥14 standard drinks per week for females during the 30 days prior
to enrollment. Informed consent was obtained from all subjects.
Exclusion criteria included a current axis I Diagnostic and
StatisticalManual ofMentalDisorders, 4th edition (DSM-IV;Amer-
ican Psychiatric Association, 1994) diagnosis of mental illness
except for nicotine or alcohol dependence, as determined by men-
tal status and psychiatric interview using the Structured Clinical
Interview for DSM-IV (First et al., 1994), and a lifetime history
of major depression, panic disorder, bipolar disorder, eating dis-
order, or thought disorder. Other exclusion criteria included a
current history of signiﬁcant medical illness as determined by
history, complete physical examination, and electrocardiogram,
a positive family history of major depression (in the parents), and
those currently seeking treatment for alcohol dependence.
DESIGN
The study was designed to test the original hypothesis of the role
of 5′-HTTLPR polymorphisms (LL, LS, or SS) on cue-induced
alcohol craving [see Ait-Daoud et al. (2009) for a detailed descrip-
tion of the study design]. Brieﬂy, subjects were randomized using
an urn procedure into balanced groups of LL, LS, and SS indi-
viduals of similar age and drinking level. Each participant had
four test sessions, with each session separated by at least 24 h to
allow for tryptophan reserves to be replenished. On the morn-
ing of each testing day, participants were asked to consume the
tryptophan-containing (Tryp+) or tryptophan-depleted (Tryp−)
beverage. Objective and subjective measures of craving were col-
lected at scheduled intervals throughout the experiment: three
times before cue exposure (t1–t3), just after cue exposure (t4), and
at the end of the experiment (t5), which corresponds to about an
hour after cue exposure. Exposure to the cues took place 5.5 h after
consumption of the Tryp+ or Tryp− beverage to allow sufﬁcient
time for alterations in tryptophan availability to occur (Delgado
et al., 1990, 1994).
TRYPTOPHAN DEPLETION METHOD
A detailed description of the tryptophan depletion procedure has
been given in the original publication (Ait-Daoud et al., 2009).
To summarize, tryptophan depletion was applied in a double-
blind, counterbalanced, within-subject design. Tryptophan deple-
tion was achieved through a tryptophan-deﬁcient amino acid
mixture administered 5 h prior to testing. The Tryp− beverage
contained large amino acids that compete with carrier-mediated
transport and uptake of tryptophan into the brain. The Tryp+
beverage or sham drink contained a mixture of cornstarch and
grapefruit concentrate.
End of experiments
At the end of each experimental session, participants were
provided with a meal rich in proteins that included tryptophan.
CUE CRAVING METHOD
Alcohol cue exposure procedure
A detailed description of the alcohol cue exposure appeared in the
original publication (Ait-Daoud et al., 2009). To summarize, alco-
holic drink preference (i.e., beer, liquor, or wine) was established
at screening. At the time of cue exposure, participants were seated
comfortably in a private room and presented with their alcoholic
drink of choice along with a medicine cup containing 2ml of
the drink. Participants were instructed to pick up the can or bot-
tle, open it, pour a small amount into a glass, and hold the glass
against their chin to smell the drink. They were then instructed
to take the contents of the medicine cup and swirl it around their
mouth before swallowing. Subjective measures of craving were
collected during t1–t5. At the end of the session, participants were
allowed to consume the drink to avoid habituation and extinction
of responses to the craving cues. The alcohol cue exposure task
took approximately 5min to perform.
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Neutral cue exposure procedure
Here participants were asked to choose between iced tea and
lemonade during screening.
CRAVING INSTRUMENTS
Subjective measures
Visual analog scales (VAS) of alcohol craving were adapted from
the Tiffany Craving Questionnaire. The visual analog scales of
interest included 100-mm lines with adjectival descriptions of “I
have an urge for a drink” and “I crave a drink right now” that were
anchored on the left by“not at all” and on the right by“extremely.”
GENOTYPING FOR rs1042173 POLYMORPHISMS
All DNA samples were collected at baseline for the purpose of
genotyping 5′-HTTLPR polymorphisms to randomize partici-
pants for the human laboratory experiment described above. The
alleles of rs1042173 were genotyped with pre-made TaqMan®
genotyping assays (Applied Biosystems, Foster City, CA, USA) as
reported previously (Seneviratne et al., 2009).
ETHICAL APPROVAL
Ethical approval was provided by the institutional review board at
the University of Texas Health Science Center at San Antonio.
STATISTICAL ANALYSIS
The general timeline for the assessments was t1–t3 (pre-cue), t4
(cue), t5 (post-cue). VAS questionnaires (i.e., “I have an urge for
a drink” and “I crave a drink right now”) were administered at all
time points described above for the nine different sessions. The
VAS measures were described as their mean and SE or 95% con-
ﬁdence interval (CI). For the VAS questionnaires, we selected two
outcomes: the difference between timepoints t3 and t4 and the area
under the curve of time points t3–t5 inclusive. In our analysis, the
proﬁles of the questions of interest were examined ﬁrst to ensure
use of the appropriate statistical model. Then, a linear mixed-
effects model (SAS® PROC MIXED; SAS Institute Inc., Cary, NC,
USA) was used to study the effects of treatment, genotype, and
cue as well as the two-way interaction effects between them on the
two outcomes for the VAS questionnaires. The analytical model
was adjusted for covariates that included the participant’s chrono-
logical age, average drinking level during the 90 days prior to
enrollment, and alcohol severity prior to enrollment as measured
on the subscales of severity and frequency of withdrawal and delir-
ium tremens on the Addiction Severity Index. Due to the small
sample size, Satterthwaite approximation was used for calculating
the number of degrees of freedom. Two-way interactions of treat-
ment (Tryp+ or Tryp−), genotype, and cue were ﬁrst included in
the models but were excluded from the ﬁnal model if not signiﬁ-
cant. The signiﬁcance level of all tests was speciﬁed at 0.05, and all
tests were two-sided. All analyses were carried out in SAS® version
9.2 (SAS Institute Inc.).
RESULTS
Twenty-three of the 34 participants were G-allele carriers (i.e.,
TG/GG), and 9 had the TT genotype. For two participants,
the genotype of interest was not identiﬁed; therefore, they were
not included in the analysis. All participants were male. The
mean± SD chronological age was 34.9 (10.0) for TG/GG and 34.7
(4.6) for TT; age of onset of problem drinking was 22.0 (6.9) for
TG/GG and 17.8 (2.3) for TT; baseline drinking levels were 8.5
(4.7) in the TG/GG group and 9.6 (7.5) in the TT group.
For the duration of the inpatient stay, there was no report of
alcohol withdrawal symptoms in any of the participants. All par-
ticipants tolerated well their drinks, and no one experienced any
adverse events. Tryptophan depletion achieved a 71% reduction in
5.5 h based on the measurement of free plasma tryptophan level.
With 1 day between sessions, tryptophan levels were replenished
for the next session, irrespective of whether the preceding session
was a tryptophan depletion session or a placebo session, as demon-
strated by plasma tryptophan levels that were back to baseline.
For both“urge to drink”and“crave for a drink,” there was a sig-
niﬁcant main effect of cue (p ≤ 0.01) and an interaction between
rs1042173 and cue (rs1042173∗cue) variables (p< 0.05). There
was no effect of tryptophan depletion on “urge to drink” and
“crave for a drink” (p> 0.05; Table 1).
As expected, the alcohol cue induced a greater “urge to drink”
(mean= 11.29; 95% CI= 3.82–19.76; p = 0.004) and “crave for
a drink” (mean= 10.89; 95% CI= 2.66–19.13; p = 0.010) com-
pared with the neutral cue. Upon subgrouping the study pop-
ulation based on rs1042173 genotypes, we detected a twofold
increase in both “urge to drink” and “crave for a drink” in
response to alcohol, within TT carriers (Figure 1). In TT carri-
ers, the mean difference between alcohol and neutral cue-induced
“urge to drink” was 20.12 (95% CI: 7.56–32.69; p = 0.002) and
“crave for a drink” was 20.13 (95% CI: 6.22–34.04; p = 0.005).
In contrast, within the TG/GG group, alcohol cue did not elicit
a signiﬁcantly greater response than the neutral cue. Further-
more, the “urge to drink” under the alcohol cue in TT genotype
individuals was also signiﬁcantly greater than the scores seen in
TG/GG carriers (mean difference= 11.25; 95% CI: 0.04–22.46;
p = 0.049). The difference for “crave for a drink” between the
TT and TG/GG groups was not statistically signiﬁcant, although
the magnitude of difference was similar to what we have seen
for “urge to drink” between the two genotype groups (mean dif-
ference= 11.05; 95% CI: −5.09 to 27.19; p = 0.174). Thus, it is
reasonable to argue that this discrepancy between responses to
the two variables (urge and craving) may have resulted from
lack of consistency in how the individuals interpreted the term
“craving.”
Table 1 | Analysis of variance table for the mean difference between
time points post-cue (i.e., t4) and pre-cue (i.e., t3).
Variable “Urge to drink” “Crave for a drink”
F -value p-Value F -value p-Value
Treatment (tryptophan
depletion)
1.66 0.201 0.01 0.914
rs1042173 (TT, TG/GG) 0.34 0.567 0.07 0.795
Cue 9.10 0.004 6.59 0.010
rs1042173*cue 5.58 0.021 5.01 0.028
Age of onset of
problem drinking
0.72 0.407 0.12 0.728
p-Values <0.05 are shown in bold-faced font.
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FIGURE 1 | Mean (A) “urge to drink” and (B) “crave for a drink,” as a function of rs1042173 genotypes. “Urge to drink” and “crave for a drink” were
assessed using visual analog scales (VAS) pre (t3)- and post (t4)-exposure to the alcohol and neutral cues. **p<0.01 for the comparison between the alcohol
and neutral cues within theTT genotype group.
There was no effect of tryptophan depletion or age of onset of
problem drinking on cue-induced alcohol craving.
DISCUSSION
The present study conﬁrmed our hypothesis that AD individuals
with the TT genotype, compared with G-allele carriers, would
have a higher subjective response to alcohol in Hispanic indi-
viduals. Those with the TT genotype, but not G-allele carriers,
scored higher on both of the VAS subjective craving measures in
the presence of the alcohol cue than in the presence of the neutral
cue. That is, when exposed to alcohol, TT carriers, but not the
TG/GG carriers, showed signiﬁcantly greater urge (20.12 points)
and craving (20.13 points) for drinking. Urge and craving for drug
use are often used synonymously in addiction research literature
(Rohsenow andMonti, 1999; Skinner andAubin, 2010) with a dif-
ference being that of intensity. Marlatt (1987) described urge as an
“intention to use” and craving as a “temptation to use” drugs, in
which case the latter can exist without the former (Tiffany, 1999;
Skinner and Aubin, 2010). Considering these factors and practical
concerns related to possible inconsistent interpretations among
participants, we utilized both “I have an urge for a drink” and
“I crave a drink right now” VAS questionnaire items to measure
craving. Moreover, in our study, the two questionnaire items were
highly correlated with each other (r = 0.930), and the TT geno-
type carriers had higher scores for both items in the presence of the
alcohol cue. The word “craving” in the title implies a more inclu-
sive deﬁnition, and, therefore,we did notmention both“urge”and
“crave” in the title.
These results supplement ﬁndings from our previous outpa-
tient and in vitro studies (Seneviratne et al., 2009; Johnson et al.,
2011) that showed lower 5-HTTexpression levels andmore intense
alcohol drinking behavior associated with the TT genotype. From
a biological and behavioral perspective, it could be argued that
lower 5-HTT expression levels associated with the TT genotype
may facilitate serotonergic and dopaminergic output in the reward
pathways, thereby increasing the desire for more intense drink-
ing, upon exposure to small priming doses. However, in the study
conducted by Seneviratne and colleagues, the association between
rs1042173 and drinking intensity in Hispanic individuals was not
statistically signiﬁcant although the trend was similar. One possi-
ble explanation for this lack of association is that the drinking data
were collected retrospectively by self-reports.
Interestingly, in our primary study from the same human labo-
ratory experiments, we reported on another functional polymor-
phism in SLC6A4 also associated with reduced 5-HTT expression
levels in alcoholics (Ait-Daoud et al., 2009). In that study, AD
individuals with the LL polymorphism of the 5′-HTTLPR had
greater cue-induced alcohol craving and possibly greater propen-
sity for drinking compared with S-allele carriers. These results
were further strengthened by a series of biochemical studies that
reported higher lifetime drinking associated with lower levels of
5-HT binding and uptake among L-allele carriers (Johnson et al.,
2008). In the present study, we were too limited by the rela-
tively small sample size to examine the combined effects of the
TT and LL genotypes on alcohol craving; nevertheless, it is note-
worthy that in our population, 6 of the 9 TT subjects had the LL
genotype; among G-allele carriers, only 6 of 17 possessed the LL
genotype.
An important disparity between our primary analysis and the
current study is that in the latter we did not ﬁnd an effect of trypto-
phan depletion on cue-induced alcohol craving, perhaps because
of the smaller sample size in this analysis. We also did not ﬁnd an
effect of age of onset of problem drinking on cue-induced alcohol
craving. Classifying alcoholics into clinically meaningful subtypes
usually provides better delineation of the psychopathological fac-
tors mostly associated with the manifestations and course of the
disease. An early age of onset of problem drinking is usually asso-
ciated with greater alcohol severity and has been used to factor
in the role of greater duration of drinking in different types of
research settings.
There are several important caveats that need to be con-
sidered when evaluating our results. First, this was a relatively
small human laboratory study that did not allow us to evaluate
the interactive effects between the 5′-HTTLPR and rs1042173
genotypes on cue-induced alcohol craving or the gender dif-
ferences among “genotype× treatment” groups. In this context,
our study represents a pilot human laboratory investigation that
examined the genetic effects of a functional polymorphism on
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cue-induced alcohol craving. Second, because this is a post hoc
analysis, subjects were not randomized based on their rs1042173
genotypes; thus, the frequencies of TT versus TG/GG genotypes
were not equally distributed, which could have enhanced the
observed effects. Third, our experiment was conducted in a very
controlled environment and was not designed to measure self-
administered alcohol amounts during the laboratory procedure;
this limited our capacity to infer directly the correlations between
cue-induced“urge and crave for a drink”and drinking intensity for
the same participants. It is noteworthy tomention that we deliber-
ately controlled the drinking level at enrollment to avoid drinking
variability between the two groups and to allow participants to
safely stay in an inpatient unit without signiﬁcant negative health
consequences.
Despite these limitations, we now have consistently shown
that 5-HTT expression levels are associated with the extent of
the desire to drink and the severity of drinking. More speciﬁ-
cally, we have shown that AD individuals carrying genetic vari-
ants of SLC6A4 that are associated with lower levels of 5-HTT
expression are prone to express higher reactivity to alcohol-
related cues. Furthermore, our results highlight cue-induced
alcohol craving as a homogeneous behavioral intermediate
phenotype related to a candidate gene (SLC6A4) and an under-
lying pathophysiology within the serotonergic system. Medica-
tions that curb craving for alcohol have been tested as success-
ful agents for treating alcoholism (Johnson, 2008). Therefore,
the present ﬁndings will indeed enable us to narrow down the
complexity of conducting pharmacogenetic studies by identi-
fying and targeting subpopulations of alcoholics with higher
craving.
In summary, we provide evidence of another functional poly-
morphism in SLC6A4 associated with the subjective response to
alcohol in Hispanic AD individuals. Future studies with larger
sample sizes are required to characterize better the genetic epistatic
effects that contribute to individual variation underlying human
drinking behavior.
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